Novonesis (novozymes)-ADRNVZMY
13F holders, Q1 2025 (March 31)8holders
0new positions
0sold out
$58.25avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($613K), Sterling Capital Management LLC ($397K) and S&co Inc. ($261K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q1 2025)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,451 shares bought and 253 shares sold, net +1,198 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Rhumbline Advisers | 0.00% | Add +1.3% | 10,487 | $613K |
| Sterling Capital Management LLC | 0.01% | Add +9.3% | 6,834 | $397K |
| S&co Inc. | 0.02% | No change | 4,500 | $261K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -5.1% | 1,738 | $102K |
| GAMMA Investing LLC | 0.01% | Add +72.5% | 1,732 | $101K |
| Mar Vista Investment Partners LLC | 0.00% | Reduce -17.6% | 702 | $41K |
| Brooklyn Investment Group | 0.00% | Reduce -11.7% | 68 | $4K |
| Copeland Capital Management, LLC | 0.00% | Add +26.7% | 57 | $3K |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.